MedDataX Logo

Unified Protocol for Preventing Emotional and Academic Challenges in Education (U-PEACE)

NCT06056674 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2025-08-19

No results posted yet for this study

Summary

The purpose of the study is to evaluate the feasibility and effectiveness of a program for high school students with emotional and academic challenges U-PEACE and gaining feedback on that program.

Conditions

  • Emotions

Interventions

BEHAVIORAL

U-PEACE Intervention

This program will involve about 13 group sessions, with each group session lasting approximately 40-50 minutes. The program session will be held about 2 times a week during the school day (e.g., lunch time) if the group meets in person, or at a pre-scheduled time every week if the group meets online via Zoom. Participants will learn how to better understand emotional experiences and use this understanding to embrace agency in challenging situations. Participants will develop skills to better deal with emotions by increasing awareness of what is happening in different settings and choose how to respond. Skill-building exercises may include mindfulness practices, flexible thinking, behavioral activation, problem-solving, and exposure activities.

BEHAVIORAL

SAU

Participants in this group will continue to receive standard of care within their school clinic.

Sponsors & Collaborators

  • Institute of Educational Sciences (IES)

    collaborator UNKNOWN

  • University of Miami

    lead OTHER

Principal Investigators

  • Jill Ehrenreich-May, PhD · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-05
Primary Completion
2025-12-01
Completion
2025-12-01

Countries

  • United States

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06056674 on ClinicalTrials.gov